Skip to main content
NewslettersWatchlist

TSX Composite Index(TXCX)
INDEX/TSX

Today's Change
Real-Time Last Update

Another Biotech Steals The Show Following Major Clinical Data Release

AllPennyStocks.com - AllPennyStocks.com - Wed Mar 20, 11:38AM CDT

There was some pretty substantial news coming out of Dallas, TX this morning after a biotech company shared initial clinical data from the first pediatric patient from the REVEAL Phase ½ adolescent and adult trial of TSHA-102, an investigational gene therapy, in adult females with Rett syndrome, according to a press release. 

This news comes in conjunction with JMP Securities analyst Silvan Tuerkcan reiterated his outperform rating while maintaining a $5.00 price target. Seeing that shares of Taysha Gene Therapies Inc. (Nasdaq:TSHA) closed at just $2.25/share yesterday, it’s no wonder that traders were excited to get their hands on a position of their own. Shares of this biotech reached up to $3.1762/share (+41.16%) at the early session high.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104.

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

More from The Globe

inside the market
Where are the debt vigilantes? Right now, they’re missing in action
Ian McGugan
cost of living
Ontario’s Sunshine List is now mostly a list of people who can’t afford to buy a home
Preet Banerjee
globe investor
Surfin USA: World market themes for the week ahead
Shoppers peruse clothing on display in a Costco warehouse Wednesday, March 6, 2024, in Sheridan, Colo.
market news
The close: Wall Street sharply higher as nonfarm payrolls report strengthens case for rate cuts in both the U.S. and Canada
A trader works inside a booth on the floor of the New York Stock Exchange on May 1.
opinion
What a legendary NHL career can teach us about the importance of portfolio rebalancing
Sam Sivarajan
report on business
BoC’s Macklem warns interest rates will likely fall gradually, and not to pre-pandemic levels
Bank of Canada Governor Tiff Macklem arrives to appear as a witness at a House of Commons Finance Committee in Ottawa on Thursday, May 2, 2024. THE CANADIAN PRESS/Sean Kilpatrick
top links
RBC analyst makes five changes to his ‘Global Energy Best Ideas’ list
Oil rig pumpjacks, also known as thirsty birds, extract crude from the Wilmington Field oil deposits area near Long Beach, California July 30, 2013
market news
The close: Major North American indexes higher, led by Nasdaq, amid plethora of mixed earnings
Traders work on the floor at the New York Stock Exchange in New York, Wednesday, May 1.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).